{"id":"F2016L01234","name":"National Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2016 (PB 28 of 2016)","slug":"f2016l01234","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":343198,"registerId":"commonwealth-F2016L01234-current","compilationNumber":null,"startDate":"2026-04-08","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2016 (PB 28 of 2016)","content":"![](image.001.png)\n\nPB 28 of 2016\n\nNational Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 20161\n\nNational Health Act 1953\n\nI, Julianne Quaine, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this special arrangement under subsections 100(1) and (2) of the National Health Act 1953.\n\nDated 8 July 2016\n\nJulianne Quaine\n\nAssistant Secretary\n\nPharmaceutical Access Branch\n\nPharmaceutical Benefits Division\n\nDepartment of Health\n\n1 Name of Special Arrangement\n\n(1) This Special Arrangement is the National Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2016.\n\n(2) This Special Arrangement may also be cited as PB 28 of 2016.\n\n2 Commencement\n\nThis Special Arrangement commences on the day after registration on the Federal Register of Legislation.\n\n3 Revocation\n\nThe National Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2015 (No. PB 18 of 2015) is revoked.\n\n4 Definitions\n\nIn these arrangements:\n\nAct means the National Health Act 1953.\n\napproved supplier means the approved supplier whose name, address and approval number are specified in Column 2 of the Schedule to this Special Arrangement opposite the name of the hospital in Column 1 of the Schedule.\n\nauthority prescription means an authority prescription as defined in the Regulations.\n\nhospital means the hospital whose name and address is specified in Column 1 of the Schedule to these arrangements.\n\nin-patient of the hospital means a person who occupies a bed in the hospital for the purpose of hospital treatment, but does not include a member of the staff of the hospital who is receiving treatment in his or her own quarters.\n\nmedication chart means either an electronic medication chart or a paper based medication chart.\n\nother Special Arrangement means another Special Arrangement under section 100 of the Act.\n\nRegulations means the National Health (Pharmaceutical Benefits) Regulations 1960.\n\nRules means the rules under subsection 99AAA(8) and subsection 98AC(4) of the Act.\n\nNote: Terms used in this Special Arrangement have the same meaning as in the Act – see section 13 of the Legislation Act 2003. These terms include:\n\n-   Chief Executive Medicare\n-   PBS prescriber\n-   pharmaceutical benefit\n-   Secretary\n\n5 Application of Part VII of the Act\n\n(1) Each pharmaceutical benefit supplied in accordance with this Special Arrangement is supplied under Part VII of the Act.\n\n(2) A provision of Part VII of the Act, or of regulations or other instruments made for Part VII of the Act, applies subject to this Special Arrangement.\n\n> Note: See subsection 100 (3) of the Act.\n\n6 Pharmaceutical benefits covered by this Special Arrangement\n\n(1) This Special Arrangement applies to a pharmaceutical benefit which is generally available for supply under Part VII of the Act.\n\n(2) This Special Arrangement does not apply to a pharmaceutical benefit that can only be supplied under Part VII of the Act in accordance with any other Special Arrangement under section 100 of the Act.\n\nNote: Section 85AA of the Act provides that a pharmaceutical benefit that can only be supplied under Part VII of the Act in accordance with section 100 of the Act will be the subject of a subsection 85(2A) declaration (section 100 only drug), or a determination under paragraph 85(8)(a) (section 100 only pharmaceutical benefit) or paragraph 85(8)(b) (section 100 only circumstances).\n\n7 Prescribing of Pharmaceutical Benefits\n\nA medication chart prepared and signed (in ink in their own handwriting or electronically) by a PBS prescriber on which is prescribed a pharmaceutical benefit for the treatment of the in-patient of the hospital who is named on the medication chart, will be taken to be a duly written prescription, within the meaning of\n\nregulation 19 of the Regulations, provided that:\n\n(a) the location within the hospital of the in-patient for whose treatment the medication chart was prepared will be taken to be the address of that in\\-patient for the purpose of paragraph 19(1)(d) of Regulations; and\n\n(b) the medication chart bears the number of the Medicare card, including the sub-numerate, which applies to the in-patient for whose treatment the medication chart was prepared; and\n\n(c) in the case of a medication chart prepared in respect of an in-patient of the hospital who is not a general patient within the meaning of subsection 84(1) of the Act, the medication chart bears the matters prescribed by regulation 19A of the Regulations; and\n\n(d) the medication chart bears the identification number issued by the Department of Human Services to the PBS prescriber, according to regulation 8A of the Regulations, who prescribed the pharmaceutical benefit; and\n\n(e) if the medication chart directs, pursuant to paragraph 85A(2)(b) of the Act and subparagraph 19(1)(f)(ii) of the Regulations, that the supply of the pharmaceutical benefit is to be repeated, that direction will be invalid; and\n\n(f) if the medication chart directs the supply of an increased quantity of a pharmaceutical benefit pursuant to subsection 88(6) of the Act and regulation 24 of the Regulations, that direction will be taken to be a direction to supply the maximum quantity for that benefit determined under paragraph 85A(2)(a) of the Act; and\n\n(g) the medication chart does not prescribe a pharmaceutical benefit that requires an authority prescription.\n\n8 Supply and Claiming of Pharmaceutical Benefits\n\n(1) These arrangements will apply to the supply of pharmaceutical benefits by the approved supplier specified in Column 2 of the Schedule to the in-patients of the hospitals specified in Column 1 of the Schedule.\n\n(2) The approved supplier will supply pharmaceutical benefits to in-patients of the hospital as if medication charts were original prescriptions, provided that:\n\n(a) where a medication chart contains a direction to supply more than one pharmaceutical benefit, the approved supplier must not, pursuant to regulation 26A of the Regulations, defer the supply of one or more of the benefits; and\n\n(b) in lieu of the requirements of regulation 31 of the Regulations, the approved supplier, or a person authorised for the purpose by the approved supplier, certifies on the medication chart that the pharmaceutical benefit has been supplied and the date on which it was supplied and signs his or her name.\n\n(3) The approved supplier must prepare an electronic pharmacy record in respect of each medication chart where a pharmaceutical benefit has been supplied to an in-patient of the hospital for which a claim is made under section 99AAA of the Act, and must retain that electronic pharmacy record for not less than two years after the day on which the pharmaceutical benefit was supplied.\n\n(4) The electronic pharmacy record referred to in subsection (3) must contain all information required to be included in a prescription record by the Schedule to the Rules for an online claim.\n\n(5) Subject to subsection (6), a claim by the approved supplier in respect of pharmaceutical benefits supplied to in-patients of the hospital may be furnished unaccompanied by the medication charts in respect of which pharmaceutical benefits have been supplied to in-patients of the hospital.\n\n(6) If the Secretary notifies the approved supplier that a copy of all or any of the electronic pharmacy records in respect of pharmaceutical benefits supplied to in-patients of the hospital is required to be submitted, that approved supplier shall submit a copy of each such electronic pharmacy record to the Department of Health.\n\n(7) If the Secretary notifies the hospital that a copy of all or any of the medication charts in respect of pharmaceutical benefits supplied to in-patients of the hospital is required to be submitted, the hospital shall submit a copy of each such medication chart to the Department of Health.\n\n(8) Information provided by electronic means to the Chief Executive Medicare on behalf of the Secretary by the approved supplier in respect of a claim in respect of pharmaceutical benefits supplied to in-patients of the hospital, must conform to the requirements of the Rules for an online claim and the associated provision of under co\\-payment data under section 98AC of the Act.\n\n9 Transitionals\n\n(1) If a pharmaceutical benefit was prescribed for an in-patient of a hospital under the old Arrangements, and the supply was not made prior to the commencement of this Special Arrangement, the supply of the pharmaceutical benefit is taken to have been validly prescribed under this Special Arrangement, and may be supplied to the in-patient of the hospital under this Special Arrangement.\n\n(2) In this section the old Arrangements means the National Health (Epworth and Cabrini Private Hospitals Paperless Prescribing and Claiming Trial) Special Arrangement 2015 (No. PB 18 of 2015).\n\n  \n\nTHE SCHEDULE\n\n| Column 1 – name and address of hospital                             | Column 2 – name, address and approval number of the approved supplier                                                                             |\n| ------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Epworth Eastern1 Arnold StreetBox Hill, Victoria 3128               | David Slade and Graham Slade (trading as Slade Pharmacy)1 Arnold StreetBox Hill, Victoria 3128Approval Number: 22298N                             |\n| Epworth Freemasons166 Clarendon StreetEast Melbourne, Victoria 3002 | Slade Pharmacy Services Pty Ltd (David Slade) (trading as Slade Pharmacy)166 Clarendon StreetEast Melbourne, Victoria 3002Approval Number: 23604H |\n| Epworth Freemasons320 Victoria ParadeEast Melbourne, Victoria 3002  | Slade Pharmacy Services Pty Ltd (David Slade) (trading as Slade Pharmacy)320 Victoria ParadeEast Melbourne, Victoria 3002Approval Number: 23605J  |\n| Epworth Richmond89 Bridge RoadRichmond, Victoria 3121               | David Slade and Graham Slade (trading as Slade Pharmacy)89 Bridge RoadRichmond, Victoria 3121Approval number 22287B                               |\n| Epworth Geelong145 Pigdons Rd,Waurn Ponds VIC 3216                  | Slade Pharmacy145 Pigdons RoadWaurn Ponds VIC 3216Approval Number: 24415B                                                                         |\n| Cabrini Brighton243 New StreetBrighton, Victoria 3186               | Cabrini Brighton243 New StreetBrighton, Victoria 3186Approval Number: HV266K                                                                      |\n| Cabrini Malvern183 Wattletree RoadMalvern, Victoria 3144            | Cabrini Malvern183 Wattletree RoadMalvern, Victoria 3144Approval Number: HV214Q                                                                   |","sortOrder":0}],"analysis":{"flash_summary_failed":{"failed":true,"reason":"Unauthenticated. Configure AI_GATEWAY_API_KEY or use a provider module. Learn more: https://ai-sdk.dev/unauthenticated-ai-gateway","source":"analysis-cron"},"kimi_summary":{"content_quality":"ok","complexity_score":4,"scope_assessment":{"changed":false,"description":"The legislation maintains its original narrow scope as a time-limited trial arrangement for specific private hospitals. It does not expand beyond the original intent of testing paperless prescribing and claiming for in-patients at designated facilities."},"complexity_factors":["Moderate cross-referencing: Heavy reliance on external instruments including the National Health Act 1953, National Health (Pharmaceutical Benefits) Regulations 1960, and unspecified 'Rules' under sections 99AAA and 98AC of the Act","Conditional logic with nested requirements: Section 7 contains 7 separate conditions (a)-(g) that must all be satisfied for a medication chart to be treated as a valid prescription","Defined terms: 8 explicit definitions in section 4 plus implicit definitions imported from the parent Act via the Legislation Act 2003","Specific exclusions and limitations: Multiple carve-outs including no authority prescriptions, no repeats, no deferral of supply, and specific quantity restrictions","Transitional provisions: Section 9 provides continuity rules for prescriptions written under the previous 2015 arrangement","Tabular Schedule: Seven specific hospital-pharmacy pairings with unique approval numbers that limit geographic and institutional scope"],"plain_english_summary":"This legislation authorises a time-limited trial allowing two private hospital groups in Victoria (Epworth and Cabrini) to use electronic medication charts instead of separate paper PBS prescriptions for in‑patient dispensing. Designated hospital doctors, approved pharmacy suppliers, and their patients in the listed hospitals can participate under specific safeguards (required identifiers, no repeats or authority medicines, two‑year electronic records).\n\nIt’s a confined digital health pilot to test e‑prescribing and e‑claiming efficiency while preserving audit and safety controls."},"flash_summary":{"complexity_score":5,"scope_assessment":{"changed":false,"description":"This instrument revokes the 2015 special arrangement and continues the same paperless prescribing and claiming trial limited to the hospitals and approved suppliers listed in the Schedule. It preserves prescriptions made under the old arrangement (see s3 and s9), so it maintains rather than expands the trial’s targeted scope."},"complexity_factors":["Cross-references to the National Health Act 1953, the National Health (Pharmaceutical Benefits) Regulations 1960, and the Rules — creating dependency on multiple external instruments (see definitions and ss5–6).","Conditional validity rules for medication charts (multiple required elements such as Medicare number, prescriber ID, and limits on repeats/authority prescriptions) that must be satisfied for charts to be treated as prescriptions (see s7).","Operational requirements on approved suppliers to certify supply on the chart, create an electronic pharmacy record with all online-claim fields, and retain records for two years (see s8(2)(b), s8(3)–(4)).","Secretary/Department discretion to request submission of electronic pharmacy records or copies of medication charts, imposing compliance and administrative burden on suppliers and hospitals (see s8(6)–(7)).","Specific exclusions and limits: excludes benefits requiring authority prescriptions and prevents deferred supply when multiple benefits are charted, affecting dispensing workflow (see s7(e), s8(2)(a)).","Schedule-specific application: the arrangement applies only to listed hospitals and named approved suppliers, so scope is narrow and administratively specific (Schedule).","Transitional and revocation mechanics linking to a prior special arrangement, requiring attention to continuity of prescriptions across instruments (see s3 and s9)."],"plain_english_summary":"This arrangement lets specified private hospitals and named approved suppliers treat a patient’s hospital medication chart as a valid PBS prescription so the supplier can supply PBS medicines and make electronic claims. It establishes paperless prescribing and claiming rules, requires the supplier to keep an electronic pharmacy record for at least two years, and lets the Department request records. It affects in‑patients of the listed hospitals, the named suppliers, hospitals (for record production) and the Department/Chief Executive Medicare (for claims processing)."}},"importantCases":[],"_links":{"self":"/api/acts/f2016l01234","history":"/api/acts/f2016l01234/history","analysis":"/api/acts/f2016l01234/analysis","conflicts":"/api/acts/f2016l01234/conflicts","importantCases":"/api/acts/f2016l01234/important-cases","documents":"/api/acts/f2016l01234/documents"}}